| mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron M Gagne, JI Moliva, KE Foulds, SF Andrew, BJ Flynn, AP Werner, ... Cell 185 (9), 1556-1571. e18, 2022 | 160 | 2022 |
| mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron M Gagne, JI Moliva, KE Foulds, SF Andrew, BJ Flynn, AP Werner, ... BioRxiv, 2022.02. 03.479037, 2022 | 60 | 2022 |
| Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung M Gagne, KS Corbett, BJ Flynn, KE Foulds, DA Wagner, SF Andrew, ... Cell 185 (1), 113-130. e15, 2022 | 59 | 2022 |
| From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis O Yogev, O Weissbrod, G Battistoni, D Bressan, A Naamati, I Falciatori, ... Communications Biology 6 (1), 277, 2023 | 6 | 2023 |
| mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron [Internet]. bioRxiv. 2022 … M Gagne, JI Moliva, KE Foulds, SF Andrew, BJ Flynn, AP Werner, ... | 6 | |
| Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway M Gagne, KS Corbett, BJ Flynn, KE Foulds, DA Wagner, SF Andrew, ... bioRxiv, 2021.10. 23.465542, 2021 | 5 | 2021 |
| Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis O Yogev, O Weissbrod, G Battistoni, D Bressan, A Naamti, I Falciatori, ... bioRxiv, 2022 | 4 | 2022 |
| Recommending COVID-19 vaccination for adolescents in primary care P Thompson, L McCormick, Q Huang, MB Gilkey, SA Dailey, NT Brewer Family Practice 40 (1), 1-8, 2023 | 2 | 2023 |
| Uncovering Structural Plasticity of Enterovirus A through Deep Insertional and Deletional Scanning P Dolan, W Bakhache, W Orr, L McCormick | | 2024 |
| Impact of malaria diagnostic choice on monitoring of Plasmodium falciparum prevalence estimates in the Democratic Republic of the Congo and relevance to … AO Diallo, K Banek, MM Kashamuka, JAM Bala, M Nkalani, G Kihuma, ... PLOS Global Public Health 3 (7), e0001375, 2023 | | 2023 |
| Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates JI Moliva, SF Andrew, BJ Flynn, DA Wagner, KE Foulds, M Gagne, ... bioRxiv, 2023.11. 22.567930, 2023 | | 2023 |
| RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways (preprint) M Gagne, BJ Flynn, CC Honeycutt, DR Flebbe, SF Andrew, SJ Provost, ... | | 2023 |
| RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways M Gagne, BJ Flynn, CC Honeycutt, DR Flebbe, SF Andrew, SJ Provost, ... bioRxiv, 2023.06. 09.544432, 2023 | | 2023 |
| Impact of malaria diagnostic choice on monitoring ofPlasmodium falciparumprevalence estimates in the Democratic Republic of the Congo and relevance to control … AO Diallo, K Banek, MM Kashamuka, MB JA, M Nkalani, G Kihuma, ... | | 2022 |
| Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis (preprint) O Yogev, O Weissbrod, G Battistoni, D Bressan, A Naamti, I Falciatori, ... | | 2022 |
| Molecular Markers of Antimalarial Drug Resistance in Plasmodium falciparum Parasites from Dschang, Cameroon L McCormick | | 2021 |
